Last quarter (Q4 2023), Deciphera Pharmaceuticals's total revenue was $48.29M, an increase of 32.88% from the same quarter last year. In Q4, Deciphera Pharmaceuticals's net income was $-47.19M. See Deciphera Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 162.15M	$ 163.36M	$ 134.04M	$ 96.15M	$ 42.09M	$ 25.00M
Cost of Revenue	$ 2.76M	$ 3.73M	$ 8.77M	$ -2.93M	$ 225.00K	$ 0.00
Gross Profit	$ 160.60M	$ 159.62M	$ 125.27M	$ 93.22M	$ 41.86M	$ 25.00M
Operating Expense	$ 184.29M	$ 370.58M	$ 307.99M	$ 393.29M	$ 313.05M	$ 225.73M
Operating Income	$ -37.90M	$ -210.96M	$ -182.72M	$ -300.08M	$ -271.19M	$ -200.73M
Net Non Operating Interest Income Expense	$ 21.10M	$ 16.70M	-	-	$ 4.70M	$ 8.47M
Other Income Expense	$ -16.45M	$ -16.45M	$ -4.51M	$ -113.00K	-	-
Pretax Income	$ 3.92M	$ -194.51M	$ -178.21M	$ -299.96M	$ -266.49M	$ -192.26M
Tax Provision	$ 431.00K	$ 431.00K	$ 722.00K	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -20.18M	$ -194.94M	$ -178.93M	$ -299.96M	$ -266.49M	$ -192.26M
Basic EPS	$ -2.29	$ -2.29	$ -2.37	$ -5.16	$ -4.78	$ -4.48
Diluted EPS	$ -2.29	$ -2.29	$ -2.37	$ -5.16	$ -4.78	$ -4.48
Basic Average Shares	$ 340.24M	$ 85.06M	$ 75.50M	$ 58.08M	$ 55.78M	$ 42.87M
Diluted Average Shares	$ 340.24M	$ 85.06M	$ 75.50M	$ 58.08M	$ 55.78M	$ 42.87M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 38.72M	$ 374.31M	$ 316.76M	$ 390.36M	$ 313.28M	$ 225.73M
Net Income From Continuing And Discontinued Operation	$ -194.90M	$ -194.90M	$ -178.90M	$ -299.96M	$ -266.49M	$ -192.26M
Normalized Income	$ -47.99M	$ -153.66M	$ -140.97M	-	$ -266.49M	$ -192.26M
Interest Expense	-	-	-	-	$ 0.00	$ 67.00K
EBIT	$ 14.15M	$ -194.51M	$ -178.21M	$ -299.96M	$ -266.49M	$ -192.19M
EBITDA	$ 13.59M	$ -199.81M	$ -176.61M	$ -295.18M	$ -264.18M	$ -191.36M

Currency in USD

Deciphera Pharmaceuticals Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing